Bicycle Therapeutics (BCYC) Enterprise Value (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Enterprise Value of -$559.5 million for Q1 2026, up 10.93% on a QoQ basis from -$628.1 million in Q4 2025, and up 29.45% year-over-year from -$432.2 million in Q1 2025.
Bicycle Therapeutics (BCYC) Enterprise Value (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Enterprise Value history runs 9 years deep, the most recent figure standing at -$559.5 million for Q1 2026.
- Quarterly Enterprise Value rose 29.45% year-over-year to -$559.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$559.5 million (up 29.45% YoY) and the FY2025 annual result came in at -$628.1 million, up 5.53% from the prior year.
- Enterprise Value was -$559.5 million for Q1 2026 at Bicycle Therapeutics, up from -$628.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$100.0 million in Q1 2022 and bottomed at -$961.4 million in Q2 2024.
- A 5-year average of -$543.0 million and a median of -$559.5 million in 2026 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 48.95% — and 2023, when it tumbled 193.81%.
- Bicycle Therapeutics' Enterprise Value stood at -$339.2 million in 2022, then slumped by 55.22% to -$526.4 million in 2023, then slipped by 26.31% to -$664.9 million in 2024, then advanced by 5.53% to -$628.1 million in 2025, then rose by 10.93% to -$559.5 million in 2026.
- Business Quant data shows BCYC's Enterprise Value at -$559.5 million in Q1 2026, -$628.1 million in Q4 2025, and -$648.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -559.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -559.47 Mn |
| Dec 31, 2025 | -628.11 Mn |
| Sep 30, 2025 | -648.30 Mn |
| Jun 30, 2025 | -721.50 Mn |
| Mar 31, 2025 | -792.97 Mn |
| Dec 31, 2024 | -664.90 Mn |
| Sep 30, 2024 | -890.86 Mn |
| Jun 30, 2024 | -961.36 Mn |
| Mar 31, 2024 | -457.00 Mn |
| Dec 31, 2023 | -526.42 Mn |
| Sep 30, 2023 | -572.09 Mn |
| Jun 30, 2023 | -340.43 Mn |
| Mar 31, 2023 | -293.82 Mn |
| Dec 31, 2022 | -339.15 Mn |
| Sep 30, 2022 | -361.47 Mn |
| Jun 30, 2022 | -372.80 Mn |
| Mar 31, 2022 | -100.00 Mn |
| Dec 31, 2021 | -438.68 Mn |
| Sep 30, 2021 | -259.52 Mn |
| Jun 30, 2021 | -198.74 Mn |